PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
- Resource Type
- Abstract
- Source
- In
Value in Health November 2019 22 Supplement 3:S555-S555 - Subject
- Language
- ISSN
- 1098-3015